Growth Metrics

BioLineRx (BLRX) Interest Coverage Ratio Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 15.31%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -303.06%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - 18.06%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -26.72%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,150.63%
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00 1,124.04%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1,124.04%
Sep 30, 2025 119.00%
Jun 30, 2025 201.36%
Mar 31, 2025 9.68%
Dec 31, 2024 -76.91%
Sep 30, 2024 -77.55%
Jun 30, 2024 -62.66%
Mar 31, 2024 136.92%
Dec 31, 2023 -32.44%
Sep 30, 2023 -44.31%
Jun 30, 2023 -63.03%
Mar 31, 2023 -143.01%
Dec 31, 2022 -80.42%
Sep 30, 2022 11.29%
Jun 30, 2022 -25.47%
Mar 31, 2022 79.34%
Dec 31, 2021 184.77%
Sep 30, 2021 54.73%
Jun 30, 2021 91.48%
Mar 31, 2021 10.30%
Dec 31, 2020 -4.32%
Sep 30, 2020 38.34%
Jun 30, 2020 -4.52%
Mar 31, 2020 32.40%
Dec 31, 2019 -44.84%
Sep 30, 2019 -98.03%
Jun 30, 2019 -97.17%
Mar 31, 2019 -61.22%
Dec 31, 2018 -98.32%
Sep 30, 2018 -51.99%
Jun 30, 2018 -69.93%
Mar 31, 2018 -96.36%
Dec 31, 2017 192.27%
Sep 30, 2017 4.83%
Jun 30, 2017 123.92%
Mar 31, 2017 -6.41%
Dec 31, 2016 153.46%
Sep 30, 2016 2,733.81%
Jun 30, 2016 -62.88%
Mar 31, 2016 270.88%
Dec 31, 2015 -1,078.26%
Sep 30, 2015 194.69%
Jun 30, 2015 23,068.12%
Mar 31, 2015 405.81%
Dec 31, 2014 948.70%
Sep 30, 2014 126.87%
Jun 30, 2014 -8.17%
Mar 31, 2014 330.04%